Evaluation of an artificial intelligence-based clinical trial matching system in Chinese patients with hepatocellular carcinoma: a retrospective study

Table 3 Performance of CTMS matching of 1,053 patients against two trials

Trial No.	Consider^a (No.)		Exclude^a (No.)		Accuracy (%)	Sensitivity (%)	Specificity (%)	PPV (%)	NPV (%)
Trial No.	TP	FP	TN	FN	Accuracy (%)	Sensitivity (%)	Specificity (%)	PPV (%)	NPV (%)
1	37		1016		92.9	51.9	99.1	75.7	97.4
1	28	9	990	26	92.9	51.9	99.1	75.7	97.4
2	67		986		98.0	83.5	99.0	85.1	98.9
2	57	10	975	11	98.0	83.5	99.0	85.1	98.9

^aNote: CTMS classified patients as “Consider” for potential eligibility and “Exclude” for ineligibility. Abbreviations: CTMS, clinical trial matching system; TP, true positive; FP, false positive; TN, true negative; FN, false negative; PPV, positive predictive value; and NPV, negative predictive value

ISSN: 1471-2407